# A Therapeutic Equivalence Study of Ketoconazole Cream 2%

> **NCT04203342** · PHASE3 · COMPLETED · sponsor: **Douglas Pharmaceuticals America Ltd** · enrollment: 682 (actual)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** Experimental: Ketoconazole 2% Cream (Douglas Pharmaceuticals America Ltd.)
- **DRUG:** Active comparator: Ketoconazole 2% Cream (Teva Pharmaceuticals USA)
- **DRUG:** Placebo comparator: Placebo (Douglas Pharmaceuticals America Ltd.)

## Key facts

- **NCT ID:** NCT04203342
- **Lead sponsor:** Douglas Pharmaceuticals America Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-11
- **Primary completion:** 2020-05-28
- **Final completion:** 2020-07-13
- **Target enrollment:** 682 (ACTUAL)
- **Last updated:** 2020-08-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04203342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04203342, "A Therapeutic Equivalence Study of Ketoconazole Cream 2%". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04203342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*